Skip to search boxSkip to navigationSkip to main content

The discriminative stimulus properties of cocaine: Effects of microinfusion of cocaine, a 5-HT(1A) agonist or antagonist, into the ventral tegmental area

  • Richard De La Garza
    ,
  • Patrick M. Callahan
    ,
  • Kathryn A. Cunningham(corresponding author)
*Corresponding author for this work
  • Harvard University
    ,
  • University of Texas Medical Branch at Galveston
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Serotonin (5-HT) afferents may modulate the dopamine mesoaccumbens circuit, which has been shown to be critically involved in the locomotor stimulatory, discriminative stimulus, and rewarding properties of cocaine. In the present study, we investigated the role of 5-HT(1A) receptors in the ventral tegmental area (VTA) in mediating the discriminative stimulus effects of cocaine. Male Sprague-Dawley rats were trained to discriminate cocaine (10 mg/kg) from saline in a two-lever, water-reinforced FR 20 task. After acquiring the cocaine-saline discrimination, rats were stereotaxically implanted with bilateral guide cannulae into the VTA or adjacent substantia nigra reticulata (SNR). Intraperitoneal administration of cocaine (0.625-10 mg/kg) produced a dose-related increase in drug-lever responding. Both intra-VTA and intra-SNR infusion of cocaine (12.5-50 μg/0.5 μl/side) engendered primarily saline-like responding. Microinjection of the 5-HT(1A) agonist 8-hydroxy-2-(di-N-propylamino) tetralin (DPAT; 0.1-10 μg/0.5 μl/side) or the 5-HT(1A) antagonist WAY 100635 (0.01-1.0 μg/0.5 μl/side) into the VTA or SNR did not substitute for the systemic cocaine cue. Further, intra-VTA or intra-SNR DPAT or WAY 100635 in combination with systemic doses of cocaine did not alter (i.e., attenuate or potentiate) the systemic cocaine cue. Overall, these data indicate that 5-HT(1A) receptors in the VTA do not mediate or modulate the discriminative stimulus effects of cocaine in the rat.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1-6 (6 pages)

Journal (Volume, Issue Number)

Psychopharmacology (Volume 137, Issue 1)

Publication milestones

  • Published - 1998

Publication status

Published - 1998

ISSN

0033-3158

Publication IDs

  • Scopus: 0031976654
  • PubMed: 9631950

Publication metrics

Metrics

Scopus
citations
SciVal
citations
16
SciVal
FWCI
0.57
SciVal
Author count
3
SciVal
Paper percentile
67
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
18
Captures
15

Funding Details

&p.2: wledgements The research described herein was supported by National Institute on Drug Abuse grants DA 05638 (R. D.) and DA 05708, DA 06511 and DA 00260 (K. A. C.). The authors would like to thank Dr. Andrew McCreary for his insightful comments on this manuscript and Ms. Wilma Frye for her assistance in its preparation. We also wish to express sincere appreciation to Wyeth Research Ltd (UK) for their generous gift of WAY 100635. Animals used in this study were maintained in accordance with the guidelines of the Institutional Animal Care and Use Committee of the University of Texas Medical Branch, and the “Guide for the Care and Use of Laboratory Animals” (Department of Health and Human Services, National Institutes of Health, Publication No. 85-23, revised 1985).
FunderFunding numbers
NIDA
DA 00260, R01DA006511, DA 05708, DA 05638